Members of the aminoacylase-1 (Acy1)/M20 family of aminoacylases and exopeptidases exist as either monomers or homodimers. They contain a zinc-binding domain and a second domain mediating dimerization in the latter case. The roles that both domains play in catalysis have been investigated for human Acy1 (hAcy1) by x-ray crystallography and by site-directed mutagenesis. Structure comparison of the dinuclear zinc center in a mutant of hAcy1 reported here with dizinc centers in related enzymes points to a difference in zinc ligation in the Acy1/M20 family. Mutational analysis supports catalytic roles of zinc ions, a vicinal glutamate, and a histidine from the dimerization domain. By complementing different active site mutants of hAcy1, we show that catalysis occurs at the dimer interface. Reinterpretation of the structure of a monomeric homolog, peptidase V, reveals that a domain insertion mimics dimerization. We conclude that monomeric and dimeric Acy1/M20 family members share a unique active site architecture involving both enzyme domains. The study may provide means to improve homologous carboxypeptidase G2 toward application in antibody-directed enzyme prodrug therapy.Zinc peptidases play roles in metabolic and signaling pathways throughout all kingdoms of life. A growing number of these enzymes have been found to contain two zinc ions at their active sites. Some are regarded as potential pharmaceutical targets (1). Recently, Wouters and Husain (2) pointed out that members of the MH and MF clans 1 of dizinc peptidases, together with the MC clan of monozinc peptidases display three different catalytic zinc centers that have evolved in a similar structural scaffold, which is exemplified by carboxypeptidase A of clan MC. Although they all appear to employ the same general base-like catalytic mechanism, neither all catalytic residues nor the substrate-binding sites are conserved among the three clans. A glutamate residue representing a putative catalytic base, for instance, resides in different regions of the polypeptide chain in the MH and MC clans. In the MF clan enzyme leucine aminopeptidase, a bicarbonate ion replaces the glutamate residue. Moreover, whereas the monozinc center in the MC clan is structurally equivalent to one of the two zincbinding sites in the dinuclear zinc center in the MH clan, it does not share any homology with the dinuclear zinc center in the MF clan anymore. As a consequence, members of families from each clan must be examined individually in order to gain a detailed understanding of their catalytic machineries.Aminoacylase-1 (Acy1 2 ; EC 3.5.1.14) was discovered in 1881 by virtue of its ability to hydrolyze hippuric acid in crude kidney homogenates (4) and is now classified in the M20 family of clan MH, also referred to as the Acy1 family (5). Acy1 plays a general role in the cytosolic breakdown of N ␣ -acetylated amino acids (6) generated during protein degradation (7). Other functional aminoacylase enzymes from the Acy1/M20 family (Table I) are implicated in the bacterial biosynthesi...

The aminoacylase-1/metallopeptidase 20 (Acy1/M20) family is the largest metallopeptidase family. Several crystal structures feature a metal-binding and a dimerization-mediating domain, both arranged in an extended open conformation. We have recently shown [Lindner et al. (2003) J. Biol. Chem. 278, 44496-44504] that in human Acy1 the invariant residues Glu147 and His206 from the metal-binding and the dimerization domain, respectively, are recruited to the active site from opposite dimer subunits. We hypothesized that, to facilitate this, formation of the binary complex is associated with domain closure, which would also position additional residues in the functional active site of Acy1. These would include two partially conserved dimerization domain residues: an asparagine (Asn263) and an arginine (Arg276) from the same subunit as His206 and Glu147, respectively. In this paper, we investigate the significance of the three dimerization domain residues of human Acy1 His206, Asn263, and Arg276 and, additionally, the nearby Asp274 for catalysis using site-directed mutagenesis. Enzyme complementation assays confirm the putative subunit allocations of these residues, and steady-state kinetics support roles for all of them in catalysis but only involve the Arg276 in substrate-binding. The results are consistent with a model of the closed conformation for the structure of the related enzyme carboxypeptidase G2. This study demonstrates experimentally for the first time for a member of the Acy1/M20 family that several residues outside of the metal-binding domain are involved in binding and catalysis.

The aminoacylase-1/metallopeptidase 20 (Acy1/M20) family features several l-aminoacylases useful in biocatalysis. Mammalian Acy1, in particular, has been applied in racemic resolution and reverse hydrolysis. Despite recent advances in our understanding of the active site architecture and functioning, determinants of Acy1 substrate specificity have remained uncharted. Comparison to bacterial homologues points to a sterically more restricted acyl-binding pocket for Acy1. Here we sought to map characteristics of the acyl-binding pocket of human and porcine Acy1. Toward this end, we determined Michaelis constants for an analogue series of aliphatic N-acyl- l-methionine substrates and translated the values into three-dimensional quantitative structure-activity relationship models employing the minimal topological difference-partial least square method. The QSAR models for the two enzymes suggest overall similar binding pockets in the acetyl-binding portion and indicate a general preference for straight-chain acyl moieties. Embedding of the QSAR map for human Acy1 in the structure of its metal-binding domain associates the side chain of Ile177 with limited acyl chain elongation which was not observed for the porcine enzyme. The topological model further supports roles of Thr347 and Leu372, which are both conserved in the porcine enzyme, in restricting acyl chain branching at the alpha- and beta-positions, respectively. Mutational analyses confirmed our predictions for Thr347 and Leu372. Moreover, the T347S variant of human Acy1 exhibited markedly increased catalytic efficiency against N-benzoylamino acids, demonstrating the potential for engineering of substrate specificity in Acy1. We discuss the more general application of the employed procedure for protein design.

No abstract